Stockreport

MaxCyte to Report First Quarter 2025 Financial Results on May 7, 2025

MaxCyte, Inc.  (MXCT) 
PDF ROCKVILLE, Md., April 10, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform te [Read more]